1. Неврология: национальное руководство / под ред. Е.И. Гусева, А.Н. Коновалова, В.И. Скворцовой, А.Б. Гехт – М.: ГЕОТАР-Медиа, 2009. – 1040 с. – (Серия «Национальные руководства»).
2. Неврология: национальное руководство. Краткое издание / под ред.
Е.И. Гусева, А.Н. Коновалова, А.Б. Гехт. – М.: ГЭОТАР-Медиа, 2014. – 688 с.
3. Martin L.J., Price A.C., Kaiser A., et al. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (review) // Int J Mol Med. – 2000. – 5: 3-13.
4. Kapur S., Kumar S., Eagland K. Anesthetic management of a parturient with neurofibromatosis 1 and Charcot-Marie-Tooth disease // J Clin Anesth. – 2007. – 19: 405-6.
5. Dermietzel R. Gap junction wiring a «new» principle in cell-to-cell communication in the nervous system? // Brain Res Brain Res Rev. – 1998. – 26: 176-183.
6. Hahn A.F., Ainsworth P.J., Naus C.C., et al. Clinical and pathological observations in men lacking the gap junction protein connexin 32 // Muscle Nerve Suppl. – 2000. – 999: 39-48.
7. Schaefer A.M., Taylor R.W., Turnbull D.M. The mitochondrial genome and mitochondrial muscle disorders // Curr Opin Pharmacol. – 2001. – 1: 288-293.
8. Hoch W., McConville J., Helms S., et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies // Nat Med. – 2001. – 7: 365-368.
9. Lindstrom J.M. Acetylcholine receptors and myasthenia // Muscle Nerve. – 2000. – 23: 453-477.
10. Lambert E.H., Eaton L.M., Rooke E.D. Defect of neuromuscular conduction associated with malignant neoplasm // Am J Physiol.– 1956.– 187: 612-613.
11. Koch M.C., Steinmeyer K., Lorenz C., Ricker K., et al. The skeletal muscle chloride channel in dominant and recessive human myotonia // Science. – 1992. – 257: 797-800.
12. Fontaine B., Khurana T.S., Hoffman E.P., et al. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene // Science. – 1990. – 250: 1000-1002.
13. Lehmann-Horn F., Jurkat-Rott K. Voltage-gated ion channels and hereditary disease // Physiol Rev. – 1999. – 79: 1317-1372.
14. Newsom-Davis J., Mills K.R. Immunological associations of acquired neuromyotonia (Isaacs’ syndrome). Report of five cases and literature review // Brain 116 (Pt 2). – 1993. – 453-469.
15. Arimura K., Sonoda Y., Watanabe O., et al. Isaacs’ syndrome as a potassium channelopathy of the nerve // Muscle Nerve Suppl.– 2002.– 11: 55-58.
16. Thiel R.E. The myotonic response to suxamethonium // Br J Anaesth. – 1967. – Vol. 39. – 815-820.
17. Ryan J.F. Malignant hyperthermia: treatment and after care // Anesth Clin North Am.– 1991. – Vol. 4. – 913-932.
18. Young C.C., Sladen R.N. Hyperthermia. In: Complications in Anesthesia, 2nd ed. – J.L. Atlee (ed.). – 2007. – 423-426.
19. Talbott E.O., Malek A.M., Lacomis D. The epidemiology of amyotrophic lateral sclerosis // Handb Clin Neurol.– 2016.– 138. – 225-38.
20. Naguib M., Lien C.A. Pharmacology of muscle relaxants and their antagonists / In Miller R.D. (ed): Miller’s Anesthesia. – 6th ed.– New York. – Churchill Livingstone. – 2005. – 481-572.
21. Dong-Chan Kim. Malignant hyperthermia // Korean J Anesthesiol. – 2012. – Nov; 63(5): 391-401.
22. Laghi F., Tobin M.J. Disorders of the respiratory muscles // American Journal Of Respiratory And Critical Care Medicine. – 2003. – Vol 168. – 10-48.
23. Juel V.C., Bleck T.P. Neuromuscular disorders in the ICU // Fink M.P., Abraham E., Vincent J.-L., Kochanek P.M. – Textbook of Critical Care (5 eds.). – 2005.
24. Andersen P.M., Abrahams S., Borasio G.D., de Carvalho M., Chio A., Van Damme P., et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force // European Journal of Neurology. – 2012. – 19: 360-375.
25. Nicholson G., Myers S. Intermediate forms of Charcot-Marie-Tooth neuropathy: a review // Neuromol Med. – 2006. – 8: 123-130.
26. Lawson V.H., Gordon Smith A., Bromberg M.B. Assessment of axonal loss in Charcot-Marie-Tooth neuropathies // Exp Neurol.– 2003184: 753–757.
27. Rudnik-Schoneborn S., Rohrig D., Nicholson G., et al. Pregnancy and delivery in Charcot-Marie-Tooth disease type 1 // Neurology. – 1993. – 43: 2011-2016.
28. Roland E.H: Muscular dystrophy // Pediatr Rev. – 2000. – 21: 233-237.
29. Brown R.H. Jr: Dystrophin-associated proteins and the muscular dystrophies // Annu Rev Med. – 1997. – 48: 457-466.
30. Emery A.E., Dreifuss F.E. Unusual type of benign X-linked muscular dystrophy // J Neurol Neurosurg Psychiatry.– 1966. – 29: 338-342.
31. Orrell R.W., Tawil R., Forrester J., et al. Definitive molecular diagnosis of facioscapulohumeral dystrophy // Neurology. – 1999. – 52: 1822-1826.
32. Johannsen S., Kranke P., Reiners K., Schuster F. Perioperative management of patients with neuromuscular disorders // Anasthesiol Intensivmed Notfallmed Schmerzther. – 2009. – Nov; 44(11-12): 748-55.
33. Zeviani M., Amati P., Savoia A. Mitochondrial myopathies // Curr. Opin. Rheumatol. – 1994. – 6: 559-567.
34. Clay A.S., Behnia M., Brown K.K. Mitochondrial disease: A pulmonary and critical care medicine perspective // Chest. – 2001. – 120: 634-648.
35. Badr A.E., Mychaskiw G. II, Eichhorn J.H. Metabolic acidosis associated with a new formulation of propofol // Anesthesiology. – 2001. – 94: 536-538.
36. Krivickas L.S., Ansved T., Suh D., et al. Contractile properties of single muscle fibers in myotonic dystrophy // Muscle Nerve. – 2000. – 23: 529-537.